Neuropathy is a broad term for any nerve damage or dysfunction in the body, while peripheral neuropathy refers specifically to damage affecting nerves outside the brain and spinal cord. In everyday medical conversations and even in many doctors’ offices, the two terms get used interchangeably, which is understandable since peripheral neuropathy is by far the most common form people encounter. But “neuropathy” technically casts a wider net, and the distinction matters once you start talking about causes, symptoms, and treatment.
Why the Word “Peripheral” Matters
Your nervous system has two main divisions. The central nervous system is the brain and spinal cord. Everything else, the web of nerves branching out to your limbs, torso, and organs, is the peripheral nervous system. When someone says “peripheral neuropathy,” they mean damage specifically to that outer network. When someone says just “neuropathy,” they could be talking about peripheral nerve damage, but they could also mean nerve problems originating in the brain or spinal cord.
Central neuropathic pain, for example, arises from injury or disease within the brain or spinal cord itself, such as after a stroke, spinal cord injury, or in conditions like multiple sclerosis.1PubMed Central. Central neuropathic pain The underlying mechanisms are different: central neuropathic pain involves maladaptive changes in the way the brain and spinal cord process pain signals, while peripheral neuropathy involves direct damage to nerves in your arms, legs, or elsewhere in the body. Treatments overlap somewhat, but the distinction shapes how a neurologist investigates and manages the problem.
In practice, when most people search for “neuropathy,” they are dealing with peripheral neuropathy. Peripheral neuropathy affects roughly one in a hundred adults worldwide, and more than 200 distinct causes have been identified.2JAMA. Peripheral Neuropathy: A Review That prevalence climbs steeply in older adults and in people with diabetes. For the rest of this article, the focus is on peripheral neuropathy and what you actually need to know about it.
The Different Patterns Peripheral Neuropathy Can Take
Not all peripheral neuropathy looks the same. Neurologists classify it based on how many nerves are involved and where the damage shows up. The three main patterns are mononeuropathy, in which a single nerve is damaged, often from compression or trauma; mononeuropathy multiplex, where several individual nerves in unrelated areas are affected; and polyneuropathy, where damage is widespread and typically caused by a systemic problem like diabetes or a toxin.3PubMed Central. Diagnostic approach to peripheral neuropathy
Carpal tunnel syndrome is a familiar example of mononeuropathy: one nerve at the wrist gets compressed, causing tingling and weakness in the hand. Polyneuropathy is far more common overall and is what most people picture when they hear the word neuropathy. It tends to be “length-dependent,” meaning the longest nerves in the body are affected first. Since the nerves running to your toes are the longest, symptoms almost always start in the feet and work their way upward over time.2JAMA. Peripheral Neuropathy: A Review This creates the classic “stocking-glove” pattern: numbness, tingling, and pain that cover the feet and lower legs first, then eventually the hands and forearms.4PubMed Central. Distal Sensory Peripheral Neuropathy: An Undervalued Determinant of Wellbeing
Small Fibers, Large Fibers, and Why Symptoms Vary So Much
Peripheral nerves are not all the same thickness, and which fibers get damaged determines what you feel. Large nerve fibers handle things like vibration sense, proprioception (knowing where your limbs are in space), and some motor functions. Small nerve fibers carry pain and temperature signals and also control certain automatic body functions like sweating and blood pressure regulation.
In diabetic polyneuropathy, many people have damage to both fiber types, a situation called mixed fiber neuropathy. Studies of diabetic polyneuropathy subtypes have found that mixed fiber involvement is the most common presentation, showing up in roughly half to nearly nine out of ten cases depending on how strictly the diagnosis is defined.5PubMed Central. Small and large fiber sensory polyneuropathy in type 2 diabetes: Influence of diagnostic criteria on neuropathy subtypes Isolated small fiber neuropathy, where only those thin pain-and-temperature fibers are affected, is less common but can be especially frustrating to diagnose because standard nerve conduction studies may come back completely normal.
When small fibers are damaged, the autonomic nervous system often takes a hit too. In one study of patients with distal small fiber neuropathy, sweat-test abnormalities were found in about 90% of patients, while the nerves controlling heart rate were less commonly affected.6PubMed. Distal small fiber neuropathy: results of tests of sweating and autonomic cardiovascular reflexes That means someone with small fiber neuropathy might notice burning feet and, seemingly unrelated, problems with how much they sweat or feeling lightheaded when standing up. Those symptoms are actually connected by the same underlying nerve damage.
What Causes Peripheral Neuropathy
Diabetes is the single biggest driver of peripheral neuropathy in Western countries, accounting for more than half of all cases.2JAMA. Peripheral Neuropathy: A Review Prolonged high blood sugar sets off a cascade of metabolic problems inside nerve cells, including excess buildup of sugar alcohols through what is called the polyol pathway, formation of damaging sugar-protein compounds, inflammatory cytokine release, and overwhelming oxidative stress.7PubMed Central. Mechanism of diabetic neuropathy: Where are we now and where to go? The result is gradual nerve injury that often involves sensory symptoms like pain and numbness, mild weakness, and autonomic symptoms such as drops in blood pressure upon standing.
Chemotherapy is another major cause. Chemotherapy-induced peripheral neuropathy affects anywhere from about one in five to more than four in five cancer patients depending on the drug and dosing regimen.8PubMed Central. Mechanisms of Chemotherapy-Induced Peripheral Neuropathy Platinum-based drugs, taxanes, and several other classes of chemotherapy agents can damage sensory, motor, and autonomic neurons. For some patients, the neuropathy resolves after treatment ends; for others, it becomes a permanent side effect that outlasts the cancer itself.
Beyond diabetes and chemotherapy, the list of causes is long: alcohol abuse, vitamin deficiencies (especially B12), autoimmune diseases, infections, kidney disease, inherited conditions, and physical trauma. Guillain-Barré syndrome is a dramatic example of an acute peripheral neuropathy in which the immune system attacks the nerve lining. Even with treatment using intravenous immunoglobulin or plasma exchange, mortality remains around 8%, and roughly one in five patients is left with lasting disability.9PubMed Central. Guillain Barré syndrome In about a quarter of peripheral neuropathy cases, no cause can be identified at all, a frustrating situation that doctors call idiopathic neuropathy.
How Peripheral Neuropathy Is Diagnosed
The standard first-line test is a nerve conduction study, often paired with electromyography. These tests measure how fast electrical signals travel through your nerves and how well your muscles respond. They are good at picking up damage to large nerve fibers, but they have a major blind spot: small fiber neuropathy often produces completely normal results on these tests, because the small fibers are too thin to register on standard electrodes.
For suspected small fiber neuropathy, skin biopsy has become the go-to diagnostic tool. A small punch biopsy, usually from the lower leg, allows a pathologist to count the density of tiny nerve fibers in the outer layer of skin. European and international neurology societies have given this technique their highest recommendation for confirming small fiber neuropathy.10PubMed. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy The procedure itself is quick, requiring only a tiny piece of skin, and the discomfort is minimal.11PubMed Central. Investigation of nerve fibers in the skin by biopsy: technical aspects, indications, and contribution to diagnosis of small-fiber neuropathy
Blood work is also a standard part of the evaluation, aimed at identifying treatable causes. Common tests screen for diabetes, vitamin B12 deficiency, thyroid problems, kidney function, and markers of autoimmune disease. If the pattern of nerve damage is unusual, like affecting only one side or appearing suddenly, further workup may include imaging or lumbar puncture to look for inflammatory or structural causes.
Treating Neuropathic Pain
Treating the underlying cause, when one exists, is the single most important step. Getting blood sugar under control can slow the progression of diabetic neuropathy. Correcting a B12 deficiency can reverse nerve damage if caught early. Stopping a toxic medication can allow nerves to recover. But when the cause cannot be fully treated, or when damage has already accumulated, symptom management becomes the focus.
First-line medications for neuropathic pain fall into two main groups: certain antidepressants and anticonvulsants. Tricyclic antidepressants work in part by blocking the reuptake of serotonin and noradrenaline, strengthening the body’s own pain-dampening pathways. Their pain-relieving effect is independent of their antidepressant effect and occurs at much lower doses than are used for depression.12Pain Medicine. A Comprehensive Algorithm for Management of Neuropathic Pain Newer antidepressants like duloxetine work through a similar mechanism with fewer side effects.
Gabapentin and pregabalin, originally developed as anti-seizure medications, are now among the most widely prescribed drugs for neuropathic pain. They work primarily by binding to a specific subunit on calcium channels in nerve cells, which reduces the release of excitatory chemical signals and dials down spinal cord sensitization.13PubMed. Implications and mechanism of action of gabapentin in neuropathic pain Gabapentin is considered a first-line option for diabetic neuropathy and postherpetic neuralgia in particular. Both antidepressants and gabapentinoids also appear to activate the brain’s descending noradrenergic pain-inhibition system and may have anti-inflammatory effects.14PubMed. Antidepressants and gabapentinoids in neuropathic pain: Mechanistic insights
Topical treatments offer another approach. Lidocaine patches reduce ectopic firing in peripheral nerves at the site of pain. High-concentration capsaicin patches work by overstimulating and then desensitizing pain-carrying nerve fibers, eventually depleting the chemical signals they use to transmit pain.12Pain Medicine. A Comprehensive Algorithm for Management of Neuropathic Pain These topical options are especially useful for people who cannot tolerate systemic medications or who have localized symptoms.
Can Peripheral Nerves Heal?
One genuine advantage the peripheral nervous system has over the central nervous system is some capacity for regeneration. Schwann cells, the support cells that wrap around peripheral nerve fibers, play a key role: after injury, they shift into a repair mode, clearing debris and forming a scaffold that regenerating nerve fibers can follow.15Orthopedic Reviews. Regenerative Medicine: A New Horizon in Peripheral Nerve Injury and Repair This is why, for instance, some people regain feeling after a nerve is compressed and then released surgically.
But that regenerative ability has limits. If the nerve cell body itself is destroyed, or if the Schwann cells are too badly damaged, regeneration stalls. Peripheral nerves regrow slowly, on the order of about a millimeter a day, which means recovery from significant nerve damage can take months or years, and it may be incomplete. Chronic conditions like diabetes create an environment of ongoing injury that undermines repair even as it occurs. The result is often a slow net loss of nerve function over time despite the body’s best attempts at self-repair.
Exercise as a Real Treatment Tool
Exercise is one of the few interventions that has consistent evidence behind it for peripheral neuropathy, and it is underused. Because many of the most common causes of peripheral neuropathy cannot be fully cured, understanding that regular physical activity can both help prevent worsening and reduce existing symptoms is genuinely useful.16PubMed Central. Benefits of exercise intervention in reducing neuropathic pain
A systematic review with meta-analysis pooling data from dozens of studies found that exercise programs improved balance, nerve conduction speed, blood sugar control, and quality of life in people with diabetic peripheral neuropathy, and improved balance, quality of life, and neuropathy-related symptoms in people with chemotherapy-induced peripheral neuropathy.17PubMed. Exercise and Neuropathy: Systematic Review with Meta-Analysis An umbrella review pulling together multiple meta-analyses confirmed significant improvements in blood sugar markers, neuropathic symptoms, physical function, and balance in people with diabetic peripheral neuropathy.18PubMed Central. Impact of Exercise Training in Patients with Diabetic Peripheral Neuropathy: An Umbrella Review
The challenge is that neuropathy itself makes exercise harder. Numbness in the feet increases fall risk, and pain can make even walking unpleasant. Starting with low-impact activities like swimming, cycling, or seated exercises can help build confidence and fitness without putting too much demand on unsteady feet. Working with a physical therapist who understands neuropathy can make a real difference in finding a program that is both safe and effective.
How Neuropathic Pain Affects Daily Life
The burden of peripheral neuropathy extends well beyond the nerves themselves. Chronic neuropathic pain is strongly linked to poor sleep quality and depression. A study of patients with combat-related extremity injuries found that those with neuropathic pain had significantly higher pain scores, worse sleep quality, and greater sleep disturbance compared to similar patients without neuropathic pain. About three-quarters of the neuropathic pain group had poor sleep quality.19PubMed Central. The effect of neuropathic pain on quality of life, depression levels, and sleep quality in patients with combat-related extremity injuries
Pain that worsens at night is a common complaint. When you are lying in bed with fewer distractions, nerve pain can feel more intense, and the burning or tingling sensations that were manageable during the day become difficult to ignore. This creates a vicious cycle: poor sleep increases pain sensitivity, which leads to worse sleep, which feeds back into more pain. Addressing sleep alongside pain management, rather than treating them as separate problems, tends to produce better outcomes.
Balance and mobility loss also carry real consequences. Falls are one of the most common and dangerous complications of peripheral neuropathy, especially in older adults. When the nerves in your feet cannot reliably tell your brain where the ground is, your body compensates with stiffer, less efficient movement patterns that increase fatigue and further raise fall risk. This is one reason exercise programs that include balance training are especially valuable for people with neuropathy.
Emerging Research Directions
Current treatments manage symptoms but rarely reverse nerve damage, which makes research into neuroprotection and regeneration a priority. One area of interest involves palmitoylethanolamide (PEA), a naturally occurring fatty acid compound that the body produces during inflammation. In animal models, PEA not only reduced pain but appeared to protect nerves from structural damage, preserving myelin thickness and axon diameter in injured nerves. Those protective effects depended on a specific receptor pathway, and when that receptor was absent, PEA failed to provide either pain relief or nerve protection.20PubMed Central. Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-alpha-mediated mechanism This kind of finding is still preclinical, meaning it has been demonstrated in mice but not proven in human trials. Still, identifying compounds that could prevent nerve damage rather than just mask the pain represents a genuinely different approach from what is currently available.
Gene therapy, stem cell treatments, and bioengineered nerve conduits are also under active investigation for more severe peripheral nerve injuries, particularly traumatic ones. The science of nerve regeneration has advanced considerably in the last two decades, but translating laboratory success into reliable clinical treatments remains slow. For now, the most practical advances are better diagnostic tools, like refined skin biopsy techniques, and a growing body of evidence supporting exercise and multimodal pain management as effective strategies for living with peripheral neuropathy rather than waiting for a cure.